glp-1 concentration metabolite GLP-1(9–36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion | Diabetologia GLP-1 Receptor Agonist Market Size

1 Although oral and perioral pigmentation may be physiologic in nature, particularly in individuals with a darker complexion, throughout the course of disease it is possible for the oral mucosa and perioral tissues to assume a variety of discolorations, including brown, blue, gray, and black

These outcomes made dual therapy attractive for patients with obesity and type 2 diabetes who failed to reach targets on monotherapy

doi: 10.1146/annurev.pharmtox.42.083001.144616 86 DenuJMTannerKG

Eight respiratory conditions: stable COPD, acute exacerbations of COPD (AECOPD), tuberculosis (TB), and anti-tubercular druginduced liver injury (AT-DILI), non-cystic fibrosis bronchiectasis, cystic fibrosis (CF), bacterial and viral infections, interstitial lung disease (ILD), and asthma were studied and discussed